迪威爾(688377.SH):公司深海產品競爭對手主要來自歐美供應商
格隆匯8月3日丨迪威爾(688377.SH)近期在接待機構投資者調研時表示,公司深海產品的競爭對手主要來自歐美供應商,均為非上市公司,他們起步較早、積累了深厚的技術儲備和豐富的製造經驗,在深海等高端產品的整體制造技術及工藝水平方面仍保持着一定的優勢,他們的部分業務與公司的業務領域或某些關鍵工序存在着競爭。隨着國內工業配套的不斷完備,以及各類技術人才的不斷儲備,包括公司在內的國內油氣設備製造企業的實力不斷增強。公司通過持續研發投入及不斷延伸產業鏈,不斷提升深海等高端產品的製造能力,因此獲得客户的高度認可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.